Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-09

Clinical Trial Update: A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee [Phase 3]

View source ↗

Summary

A Phase 3 randomized study evaluated the efficacy and safety of intra-articular Ampion for knee osteoarthritis; the trial is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ampion

Snippet

Sponsor: Ampio Pharmaceuticals. Inc. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2022-08-09